Close Menu

Beckman Coulter

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Danaher today reported a 46 percent increase in sales year over year for the third quarter, beating analysts' estimates on the top and bottom line.

Indiana University's Center for Genomics and Bioinformatics has inked a deal with Beckman Coulter to develop genomics applications that can identify toxins that are harmful to the environment and human health.

By a GenomeWeb staff reporter NEW YORK (GenomeWeb News) – Beckman Coulter's president has issued a letter to employees informing them that 8 percent of the company's workforce will be laid off as part of the company's restructuring.

By Bernadette Toner
This article was originally published Aug. 19.

The companies have reached a settlement in an intellectual property lawsuit related to technology for isolating and purifying nucleic acids.

During a conference call, Danaher's CEO said that although issues surrounding broad quality systems at Beckman Coulter, as well issues with FDA are improving, there "is plenty of work ahead of us."

Paired Ends: Jul 19, 2011

Premium

Thomas Schinecker, Kip Miller, Kevin McKernan

New Products: Jul 19, 2011

Premium

Beckman Coulter Genomics Target Capture Sequencing Service; Illumina TruSeq Custom Enrichment; Ion Torrent Barcoding, Library Quantitation, Ion Sphere Control Kits

Beckman Coulter announced changes to its board, Steven Salzberg moves to Johns Hopkins, Complete Genomics names a new senior vice president and chief commercial officer, and more.

Pages

NPR reports that graduate students in the US are helping with SARS-CoV-2 testing.

Politico reports President Donald Trump has signed the $2 trillion coronavirus relief package.

A new analysis finds that peer review improves the quality of preprints just a little bit, according to ScienceInsider.

In PLOS this week: epigenetic drug triggers anti-viral activity, viral diversity among individuals with HIV experiencing virological failure, and more.